Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luke F Peterson

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Biochemical Pharmacology|October 31, 2009
Targets and effectors of the cellular response to aurora kinase inhibitor MK-0457 (VX-680) in imatinib sensitive and resistant chronic myelogenous leukemiaNicholas J Donato, Dexing Fang, Hanshi Sun, et al.
Molecular and Cellular Biology|October 4, 2006
AML1/RUNX1 phosphorylation by cyclin-dependent kinases regulates the degradation of AML1/RUNX1 by the anaphase-promoting complexJoseph R Biggs, Luke F Peterson, Youhong Zhang, et al.
Cancer Research|November 4, 2010
Deubiquitinase inhibition by small-molecule WP1130 triggers aggresome formation and tumor cell apoptosisVaibhav Kapuria, Luke F Peterson, Dexing Fang, et al.
Molecular Cancer Research : MCR|July 28, 2005
Phosphorylation of AML1/RUNX1 regulates its degradation and nuclear matrix associationJoseph R Biggs, Youhong Zhang, Luke F Peterson, et al.
Oncotarget|July 2, 2014
Usp5 links suppression of p53 and FAS levels in melanoma to the BRAF pathwayHarish Potu, Luke F Peterson, Anupama Pal, et al.
Leukemia|April 15, 2026
Activity of PROTAC MDM2 degrader in primary leukemia cells and PDX modelsMalathi Kandarpa, Luke F Peterson, Harish Potu, et al.
Blood|January 2, 2007
A leukemia fusion protein attenuates the spindle checkpoint and promotes aneuploidyAnita Boyapati, Ming Yan, Luke F Peterson, et al.
Molecular and Cellular Biology|November 17, 2005
The hematopoietic transcription factor AML1 (RUNX1) is negatively regulated by the cell cycle protein cyclin D3Luke F Peterson, Anita Boyapati, Velvizhi Ranganathan, et al.
Biochemical Pharmacology|May 31, 2011
Protein cross-linking as a novel mechanism of action of a ubiquitin-activating enzyme inhibitor with anti-tumor activityVaibhav Kapuria, Luke F Peterson, H D Hollis Showalter, et al.
Blood|January 21, 2011
Bcr-Abl ubiquitination and Usp9x inhibition block kinase signaling and promote CML cell apoptosisHanshi Sun, Vaibhav Kapuria, Luke F Peterson, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Biochemical Pharmacology|October 31, 2009
Targets and effectors of the cellular response to aurora kinase inhibitor MK-0457 (VX-680) in imatinib sensitive and resistant chronic myelogenous leukemiaNicholas J Donato, Dexing Fang, Hanshi Sun, et al.
Molecular and Cellular Biology|October 4, 2006
AML1/RUNX1 phosphorylation by cyclin-dependent kinases regulates the degradation of AML1/RUNX1 by the anaphase-promoting complexJoseph R Biggs, Luke F Peterson, Youhong Zhang, et al.
Cancer Research|November 4, 2010
Deubiquitinase inhibition by small-molecule WP1130 triggers aggresome formation and tumor cell apoptosisVaibhav Kapuria, Luke F Peterson, Dexing Fang, et al.
Molecular Cancer Research : MCR|July 28, 2005
Phosphorylation of AML1/RUNX1 regulates its degradation and nuclear matrix associationJoseph R Biggs, Youhong Zhang, Luke F Peterson, et al.
Oncotarget|July 2, 2014
Usp5 links suppression of p53 and FAS levels in melanoma to the BRAF pathwayHarish Potu, Luke F Peterson, Anupama Pal, et al.
Leukemia|April 15, 2026
Activity of PROTAC MDM2 degrader in primary leukemia cells and PDX modelsMalathi Kandarpa, Luke F Peterson, Harish Potu, et al.
Blood|January 2, 2007
A leukemia fusion protein attenuates the spindle checkpoint and promotes aneuploidyAnita Boyapati, Ming Yan, Luke F Peterson, et al.
Molecular and Cellular Biology|November 17, 2005
The hematopoietic transcription factor AML1 (RUNX1) is negatively regulated by the cell cycle protein cyclin D3Luke F Peterson, Anita Boyapati, Velvizhi Ranganathan, et al.
Biochemical Pharmacology|May 31, 2011
Protein cross-linking as a novel mechanism of action of a ubiquitin-activating enzyme inhibitor with anti-tumor activityVaibhav Kapuria, Luke F Peterson, H D Hollis Showalter, et al.
Blood|January 21, 2011
Bcr-Abl ubiquitination and Usp9x inhibition block kinase signaling and promote CML cell apoptosisHanshi Sun, Vaibhav Kapuria, Luke F Peterson, et al.
Pageof 4